Maki Murakoshi

Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-Ay/Ta mice

Mitsuo Tanimoto, Tomohito Gohda, Shigeru Kaneko et al. · Metabolism · 2007 · 91 citations

Renal Function, Biochemistry, Kk-ay/ta Mice +9

Attenuating effect of angiotensin-(1–7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A^y/Ta mice

Ju-Young Moon, Mitsuo Tanimoto, Tomohito Gohda et al. · American Journal of Physiology-Renal Physiology · 2011 · 85 citations

Renal Inflammation, Ang Ii, Oxidative Stress +26

Role of the TNF pathway in the progression of diabetic nephropathy in KK-A^ymice

Keisuke Omote, Tomohito Gohda, Maki Murakoshi et al. · American Journal of Physiology-Renal Physiology · 2014 · 76 citations · Full text

Renal Pathology, Immunology, Renal Inflammation +23

Glomerular changes in the KK‐A^y/Ta mouse: A possible model for human type 2 diabetic nephropathy

Takamichi Ito, Mitsuo Tanimoto, Kaori Yamada et al. · Nephrology · 2006 · 62 citations · Full text

Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis

Tomohito Gohda, Shuntaro Maruyama, Nozomu Kamei et al. · Scientific Reports · 2017 · 60 citations · Full text